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Abstract
Background: Studies seeking to estimate the burden of influenza among
hospitalized adults often use case definitions that require presence of pneumonia.
The goal of this study was to assess the extent to which restricting influenza testing
to adults hospitalized with pneumonia could underestimate the total burden of
hospitalized influenza disease.
Methods: We conducted a modelling study using the complete State Inpatient
Databases from Arizona, California, and Washington and regional influenza
surveillance data acquired from CDC from January 2003 through March 2009. The
exposures of interest were positive laboratory tests for influenza A (H1N1),
influenza A (H3N2), and influenza B from two contiguous US Federal Regions
encompassing the study area. We identified the two outcomes of interest by ICD-9-
CM code: respiratory and circulatory hospitalizations, as well as critical illness
hospitalizations (acute respiratory failure, severe sepsis, and in-hospital death). We
linked the hospitalization datasets with the virus surveillance datasets by
geographic region and month of hospitalization. We used negative binomial
regression models to estimate the number of influenza-associated events for the
outcomes of interest. We sub-categorized these events to include all outcomes with
or without pneumonia diagnosis codes.
Results:We estimated that there were 80,834 (95% CI 29,214–174,033) influenza-
associated respiratory and circulatory hospitalizations and 26,760 (95% CI 14,541–
47,464) influenza-associated critical illness hospitalizations. When a pneumonia
diagnosis was excluded, the estimated number of influenza-associated respiratory
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and circulatory hospitalizations was 24,816 (95% CI 6,342–92,624). The estimated
number of influenza-associated critical illness hospitalizations was 8,213 (95% CI
3,764–20,799). Around 30% of both influenza-associated respiratory and
circulatory hospitalizations, as well as influenza-associated critical illness
hospitalizations did not have pneumonia diagnosis codes.
Conclusions: Surveillance studies which only consider hospitalizations that
include a diagnosis of pneumonia may underestimate the total burden of influenza
hospitalizations.
Introduction
Policy makers who implement influenza vaccine programs or interventions to
increase influenza vaccine coverage must first understand the epidemiology of
influenza in the targeted population. For example, results of studies of severe
influenza morbidity and mortality influenced the World Health Organization
(WHO) to develop a policy to broaden influenza vaccination programs to cover
pregnant women [1]. Similarly, epidemiologic data on the burden of pediatric
influenza disease were instrumental in recent decisions by the United States and
the United Kingdom to expand influenza vaccine recommendations to cover all
children [1–3]. Most high-income, temperate countries have identified adults,
particularly elderly adults, as being a high-risk group for influenza complications
and death, and therefore a priority group for vaccine receipt [1, 2]. In the United
States, over 23,000 adults, mostly elderly, are estimated to die from influenza and
its complications yearly, though annual mortality estimates vary considerably
from year to year [4]. Because little influenza surveillance is conducted in low-
resource countries, it is unknown whether there is a similar disproportionate
burden of adult influenza in these settings.
In an effort to standardize influenza surveillance and to increase influenza
morbidity data collection from low resource settings, the WHO established
guidelines to standardize influenza surveillance worldwide and developed tools to
use such data to estimate the burden of severe influenza disease [5, 6]. The WHO
initiative to standardize hospitalized influenza surveillance has focused on
identification of patients with severe acute respiratory infections (SARI) in
sentinel hospitals, with collection of epidemiologic data and clinical specimens for
influenza-specific laboratory testing limited to these patients [6]. To date,
published SARI surveillance studies use evidence of hospitalization for acute
febrile, lower respiratory tract illness as the case definition for study entry and
influenza testing [7–16]. However, influenza virus infection can precipitate a wide
range of processes necessitating hospital care, and case definitions that require
evidence of acute lower respiratory tract infection will overlook non-pneumonia
complications of influenza, including exacerbations of asthma, chronic obstruc-
tive lung disease, and congestive heart failure [17].
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The goal of this study was to assess the extent to which restricting influenza
testing to adults hospitalized with pneumonia may underestimate the total burden
of hospitalized influenza disease. We hypothesized that the burden of influenza




We conducted a modelling study to estimate the number of adult influenza-
associated hospitalizations overall and among those without pneumonia
diagnoses in Arizona, California, and Washington from January 2003 through
March 2009. We used state hospitalization databases from the Healthcare Cost
and Utilization Project (HCUP) and regional influenza surveillance data from the
US Centers for Disease Control and Prevention (CDC) [18, 19]. Our outcomes of
interest were respiratory and circulatory hospitalizations and critical illness
hospitalizations defined using ICD-9-CM codes. Our exposures of interest were
positive tests for influenza from regional surveillance. We linked the datasets by
calendar month and geographic region. We then used negative-binomial
regression models to estimate the number of influenza-associated outcomes with
or without pneumonia diagnosis.
Influenza surveillance dataset
Regional surveillance data for influenza A (H3N2), influenza A (H1N1), influenza
B for US Federal Regions 9 (AZ, CA, HI, NV) and 10 (AK, ID, OR, WA) were
obtained from the CDC [18]. We collapsed the week-level data by month to
permit linkage to the hospitalization dataset. We defined the influenza
surveillance year as July through June of the next calendar year in order to capture
an entire influenza season annually. For unsubtyped influenza A viruses, we
assumed that the subtypes were proportional to the total influenza A (H3N2) and
influenza A (H1N1) viruses detected over the entire surveillance year [20, 21]. We
next divided the total number of positive tests per influenza type and subtype by
the total number of tests performed in the surveillance year to reduce possible bias
associated with differences in surveillance testing over time [20, 21].
Hospitalization dataset
We used the State Inpatient Database (SID) for Arizona, California, and
Washington from the Healthcare Cost and Utilization Project (HCUP) [19]. The
outcomes of interest were defined by ICD-9-CM diagnosis and procedure codes
(Table S1). Respiratory and circulatory outcomes were defined as any
hospitalizations with ICD-9-CM codes 390-519 [21, 22]. Critical illness hospita-
lizations were defined as any hospitalizations with ICD-9-CM diagnosis or
procedure codes for acute respiratory failure (96.7 and any of 518.5, 518.81, or
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518.82) [23], severe sepsis (995.92, 785.52, or any codes for infection and organ
dysfunction) [24–26], or in-hospital death (HCUP variable died 51) [27]. We
categorized the outcomes by five adult age groups: 18–49 years, 50–64 years, 65–
74 years, 75–84 years, and 85 years and older, as well as by presence or absence of
ICD-9-CM diagnoses for pneumonia (480–486) excluding concurrent influenza
diagnosis codes (487).
Statistical analysis
We used negative binomial regression models similar to those developed by CDC
to estimate US influenza-associated hospitalizations [4, 21, 22]. We recently
adapted this model to estimate the incidence of influenza-associated acute
respiratory failure [20]. A detailed description of our statistical methods has been
published [20].
Briefly, age group-specific negative binomial regression models were fit to
monthly events in the three states of interest. Covariates for the standardized
proportion of specimens testing positive each month for influenza A (H1N1),
influenza A (H3N2), and influenza B in the two US Federal Regions were included
in the models. Additional covariates accounted for seasonal trend, secular trend,
and state. Using the fitted (baseline) model, we then calculated the number of the
influenza-associated outcomes for each influenza type/subtype as the difference
between the outcomes estimated from the original data and the outcomes with the
given influenza type term set to zero (the difference was set to zero when
negative). This method defines the difference between predicted and baseline
events as influenza-associated events. The baseline accounted for the seasonality of
non-influenza associated events, some of which may be associated with other
respiratory pathogens and some of which are likely due to non-infectious causes.
Only a small fraction of events occurring during the winter are thus attributed to
influenza infections. The modeled monthly outcomes were summed for each viral
covariate across the study period and states for each outcome and age category.
We calculated 95% confidence intervals for influenza-associated events using the
non-parametric bootstrap [28].
This study received exempt review status from the Human Subjects Division at
the University of Washington (#HSD No. 36982). No consent was obtained for
the use of patient-level data. The records analyzed were anonymized and de-
identified prior to analysis. Analyses were performed with SAS (version 9.3; Cary,
NC) and R (version 3.0.1; Austria, Vienna) statistical software.
Results
During the study period, there were 28,176,969 hospitalizations in the three states;
16,044,193 (57% of total) hospitalizations were for respiratory or circulatory
outcomes, while 2,066,072 (7% of total) were for critical illness outcomes
(Table 1). Almost all of the critical illness hospitalizations (94.1%) had ICD-9
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codes for respiratory and circulatory diagnoses, while few respiratory and
circulatory diagnoses had ICD-9 codes for critical illness (12.1%). Using
multivariate binomial regression models, we estimated that there were 80,834
(95% CI 29,214–174,033) influenza-associated respiratory or circulatory hospi-
talizations and 26,760 (95% CI 14,541–47,464) influenza-associated critical illness
hospitalizations (Table 1). We estimated annual incidence estimates of influenza-
associated respiratory and circulatory hospitalizations for 18–49 years (14.8 per
100,000 person years), 50–64 years (24.2 per 100,000 person years, 65–74 years
(40.3 per 100,000 person years), 75–84 years (144.9 per 100,000 person years), and
>85 years (531.3 per 100,000 person years) (Table S2).
We repeated these analyses excluding outcomes that listed a diagnostic code for
pneumonia. When a pneumonia diagnosis was excluded, the estimated number of
influenza-associated respiratory or circulatory hospitalizations was 24,816 (95%
CI 6,342–92,624). The estimated number of influenza-associated critical illness
hospitalizations excluding pneumonia diagnoses was 8,213 (95% CI 3,764–
20,799). These data suggest that 31% of both the total influenza-associated
respiratory and circulatory hospitalizations and the total influenza-associated
critical illness hospitalizations do not have pneumonia diagnoses and may not be
captured by hospital-based influenza pneumonia surveillance.
Within adult age groups, we estimate that requiring pneumonia diagnoses to
define influenza-associated events would exclude from 17.0% (65 to 74 years) to
39.9% (18 to 49 years) of total influenza-associated respiratory and circulatory
hospitalizations. For influenza-associated critical illness hospitalizations, requiring
a pneumonia diagnoses would exclude from 23.3% (75 to 84 years) to 38.7% (50
to 64 years) of total events.









Pneumonia3 n, (95% CI)
Total Influenza-Associated
critical illness
Hospitalizations2 n, (95% CI)
Influenza-Associated critical
illness Hospitalizations2
without Pneumonia3 n, (95%
CI)
18–49 20,837 (6,986–42,870) 8,320 (402–25,377) 3,161 (1,108–6,491) 1,143 (122–3,536)
50–64 11,842 (0–32,712) 3,990 (0–20,081) 4,986 (2,147–10,257) 1,927 (378–5,367)
65–74 7,012 (0–31,160) 1,193 (0–16,963) 5,022 (2,213–9,253) 1,644 (356–4,232)
75–84 17,197 (2,021–46,251) 2,507 (0–22,850) 6,553 (3,039–12,759) 1,524 (81–5,489)
85+ 23,945 (9,770–42,708) 8,806 (1,121–22,373) 7,038 (3,533–12,050) 1,975 (812–4,562)
Overall 80,834 (29,214–174,033) 24,816 (6,342–92,624) 26,760 (14,541–47,464) 8,213 (3,764–20,799)
1. Outcome definitions are detailed in the Table S1. Respiratory and Circulatory Hospitalizations were defined by ICD-9-CM codes for hospitalizations with
any respiratory or circulatory diagnoses. Critical illness Hospitalizations were defined by ICD-9-CM diagnosis and procedure codes for hospitalizations with
acute respiratory failure, severe sepsis, or in-hospital death.
2. Total influenza-associated events and total influenza-associated events without pneumonia were estimated from negative binomial regression models.
3. Pneumonia defined by ICD-9-CM codes for pneumonia diagnosis codes excluding concurrent influenza diagnosis codes.
doi:10.1371/journal.pone.0113903.t001
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Conclusions
Our study found that disease modelling approaches will estimate 50% fewer cases
of influenza-associated hospitalizations if pneumonia ICD-9-CM codes are
required as compared to more sensitive respiratory or circulatory ICD-9-CM
codes. This study has implications for influenza disease surveillance in hospitals
and for estimates of influenza disease burden. If adult influenza surveillance is
limited to patients with pneumonia, our data suggest that a substantial proportion
of influenza-associated hospitalizations may be missed. Such underestimates
might affect the perceived value or cost-effectiveness of influenza vaccination,
particularly in countries with only limited influenza surveillance data.
Non-pneumonia complications of influenza virus infection are more likely to
occur in older adults with chronic comorbid conditions [29]. The United States
has an older population with a higher prevalence of chronic underlying medical
conditions than typical low- or middle-income countries [30]. These demo-
graphic differences suggest that influenza-pneumonia case definitions may be
more sensitive for all-cause influenza disease in different socio-demographic
settings. A recent study from South Africa estimates that influenza associated
deaths in the elderly due to cerebrovascular disease, diabetes, or ischemic heart
disease were higher than in the United States [31], and younger adults with AIDS
in South Africa had elevated incidence of non-pneumonia influenza-attributable
mortality [32]. With increasing survival and rising prevalence of non-commu-
nicable diseases throughout the world [30], influenza-associated exacerbations of
underlying diseases will likely increase in importance.
Our study should be interpreted in the context of its limitations. The ideal
study design to address our primary objective would be prospective hospital
surveillance with sensitive specimen collection criteria for influenza testing and
standardized radiographic assessment for pneumonia. Few such studies have been
conducted, however, likely owing to the high costs of such research and the large
sample sizes needed for high precision estimates, particularly among the critically
ill. Owing to the nature of our modelling approach, caution should be taken with
direct extrapolation of our results to the individual level. Because SID databases
do not have results for microbiological investigations or particular therapies, we
are unable to calculate the number of hospitalized influenza cases, necessitating
our disease modeling approach. Similar methods have been used to estimate the
burden of influenza disease in many countries [22, 33–37], and they are
recommended by WHO to estimate influenza burden of disease when
administrative hospitalization datasets and robust influenza surveillance data are
available [5]. A recent study has validated our approach to estimating influenza-
associated hospitalizations against prospective surveillance for laboratory-
confirmed influenza in children [38], but there are no such validation studies in
adults. The event estimates assumed that influenza types/subtype effects are non-
negative and that virus activity is independent by type/subtype. If either of these
two assumptions were violated, we may have over-estimated the total number of
influenza-associated events. We used administrative codes to identify persons with
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acute respiratory failure, pneumonia, orsevere sepsis. While we used definitions of
these outcomes from previous clinical epidemiology research, only pneumonia
and severe sepsis have been validated against medical record review
[25, 26, 39, 40].
Influenza vaccines are safe and effective at preventing influenza disease [2].
Vaccination would likely have the highest impact in settings where influenza
morbidity is highest. Many countries will want local or regional burden of disease
data to inform estimates of vaccine program impact in order to decide among
competing public health priorities. Our study suggests that there may be a large
proportion of unmeasured severe influenza disease in the influenza literature
which must be considered in vaccine program impact calculations.
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